Evidence map›Paper›PMID 38692202›Full record

SynthesisDiagnostic microbiology and infectious disease2024

A comprehensive meta-analysis and systematic review of breath analysis in detection of COVID-19 through Volatile organic compounds.

Grace A Long, Qian Xu, Jahnavi Sunkara, Reagan Woodbury, Katherine Brown, Justin J Huang, Zhenzhen Xie, Xiaoyu Chen, Xiao-An Fu, Jiapeng Huang

Open access · greenAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Diagnostic microbiology and infectious disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
2.2field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 2 countries.

Grace A LongDepartment of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.
Qian XuBiometrics and Data Science, Fosun Pharma, Beijing, PR China.
Jahnavi SunkaraDepartment of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.
Reagan WoodburyDepartment of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.
Katherine BrownDepartment of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.
Justin J HuangDupont Manual High School, Louisville, KY, USA.
Zhenzhen XieDepartment of Chemical Engineering, University of Louisville, Louisville, KY, USA.
Xiaoyu ChenDepartment of Industrial and Systems Engineering, University at Buffalo, Buffalo, NY, USA. Electronic address: xchen325@buffalo.edu.
Xiao-An FuDepartment of Chemical Engineering, University of Louisville, Louisville, KY, USA. Electronic address: xiaoan.fu@louisville.edu.
Jiapeng HuangDepartment of Anesthesiology & Perioperative Medicine, University of Louisville, Louisville, KY, USA.. Electronic address: jiapeng.huang@louisville.edu.
University of Louisville · USFosun Pharma (China) · CN

Funding

University of Louisville Center for Integrative Environmental Health SciencesP30ES030283 · NIEHS · UNIVERSITY OF LOUISVILLE · PI Amanda Jo LeBlanc · 2020 to 2026
$10.0M
Research Design, Compliance, and Data Management (RDCD)P20GM155899 · NIGMS · UNIVERSITY OF LOUISVILLE · PI Jon Klein · 2024 to 2026
$9.3M
Low Density Neutrophils Link Inflammation and Coagulopathy in COVID-19R01HL158779 · NHLBI · UNIVERSITY OF LOUISVILLE · PI HUANG, JIAPENG, URIARTE, SILVIA M · 2022 to 2025
$2.9M
Neutrophil Heterogeneity and Immunopathogenesis of COVID-19 ARDSR01AI172873 · NIAID · UNIVERSITY OF LOUISVILLE · PI Jiapeng Huang, Silvia M Uriarte · 2023 to 2026
$2.3M
A Handheld Microchip for GC analysis of breath to screen for COVID-19U18TR003787 · NCATS · UNIVERSITY OF LOUISVILLE · PI FU, XIAO-AN, NANTZ, MICHAEL H · 2021 to 2022
$2.0M
NCATS NIH HHS U18 TR003787NHLBI NIH HHS R01 HL158779NIAID NIH HHS R01 AI172873NIEHS NIH HHS P30 ES030283NIGMS NIH HHS P20 GM155899
6 · The paper itself

Abstract

backgroundThe COVID-19 pandemic had profound global impacts on daily lives, economic stability, and healthcare systems. Diagnosis of COVID-19 infection via RT-PCR was crucial in reducing spread of disease and informing treatment management. While RT-PCR is a key diagnostic test, there is room for improvement in the development of diagnostic criteria. Identification of volatile organic compounds (VOCs) in exhaled breath provides a fast, reliable, and economically favorable alternative for disease detection.

methodsThis meta-analysis analyzed the diagnostic performance of VOC-based breath analysis in detection of COVID-19 infection. A systematic review of twenty-nine papers using the grading criteria from Newcastle-Ottawa Scale (NOS) and PRISMA guidelines was conducted.

resultsThe cumulative results showed a sensitivity of 0.92 (95 % CI, 90 %-95 %) and a specificity of 0.90 (95 % CI 87 %-93 %). Subgroup analysis by variant demonstrated strong sensitivity to the original strain compared to the Omicron and Delta variant in detection of SARS-CoV-2 infection. An additional subgroup analysis of detection methods showed eNose technology had the highest sensitivity when compared to GC-MS, GC-IMS, and high sensitivity-MS.

conclusionOverall, these results support the use of breath analysis as a new detection method of COVID-19 infection.

Indexed as

Breath TestsCOVID-19COVID-19 TestingVolatile Organic CompoundsGas Chromatography-Mass SpectrometryHumansSensitivity and SpecificityVolatile Organic CompoundsArtificial Intelligence ModelsBreath analysisCOVID-19PandemicRT-PCRVolatile organic compounds

Identifiers

PMID38692202
PMCPMC11405072
OpenAlexW4395697421

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.